Feto-maternal distribution of ropivacaine and bupivacaine after epidural administration for cesarean section

International Journal of Obstetric Anesthesia

Volumn 6, Issue 3, 1997, Pages 147-152

  Ala Kokko, T I ^a   Alahuhta, S ^a   Jouppila, P ^a   Korpi, K ^a   Westerling, P ^b   Vahakangas K ^a  

^a UNIVERSITY OF OULU   (Finland)

^b Research and Development at Scania Technical Centre   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; LOCAL ANESTHETIC AGENT; ROPIVACAINE;

ADULT; ARTICLE; BINDING AFFINITY; CESAREAN SECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; EPIDURAL ANESTHESIA; EPIDURAL DRUG ADMINISTRATION; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID SOLUBILITY; LIPOPHILICITY; MATERNAL BLOOD; NORMAL HUMAN; PLACENTAL TRANSFER; PLASMA PROTEIN BINDING; RANDOMIZED CONTROLLED TRIAL; UMBILICAL CORD BLOOD;

EID: 0030788524     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-289X(97)80078-7     Document Type: Article

References (33)

1. Rosenberg P H, Kyttä J, Alila A. Absorption of bupivacaine, etidocaine, lignocaine and ropivacaine into h-heptane, rat sciatic nerve and human extradural and subcutaneous fat. Br J Anaesth 1986; 58: 310-314
2. Åkerman B, Hellberg I-B, Trossvik C. Primary evaluation of the local anaesthetic properties of the amino amide agent ropivacaine (LEA 103). Acta Anaesthesiol Scand 1988; 32: 571-578
3. Lee A, Fagan D, Lamont M, Tucker G T, Halldin M, Scott D B. Disposition kinetics of ropivacaine in humans. Anesth Analg. 1989; 69: 736-738
4. Arthur G R, Feldman H S, Covino B G. Comparative pharmacokinetics of bupivacaine and ropivacaine, a new amide local anesthetic. Anesth Analg 1988; 67: 1053-1058
5. Katz J A, Brindenbaugh P O, Knarr D C, Helton S H, Denson D D. Pharmacodynamics and pharmacokinetics of epidural ropivacaine in humans. Anesth Analg 1990; 70: 16-21
6. Feldman H S, Covino B G. Comparative motor-blocking effects of bupivacaine and ropivacaine, a new amino amide local anesthetic, in the rat and dog. Anesth Analg 1988; 67: 1047-1052
7. Concepcion M, Arthur G R, Steele S M, Bader A M, Covino B G. A new local anesthetic, ropivacaine. Its epidural effects in humans. Anesth Analg 1990; 70: 80-85
8. Zaric D, Nydahl P-A, Philipson L, Samuelsson L, Heierson A, Axelsson K. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2% and 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers. A double-blind study. Reg Anesth 1996; 21: 14-25
9. Knudsen K, Beckman M, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects during intravenous infusions of ropivacaine, bupivacaine and placebo in healthy volunteers (abstract). In: The International Monitor. XIV Annual ESRA Congress 1995: p15.
10. Reiz S, Häggmark S, Johansson G, Nath S. Cardiotoxicity of ropivacaine. A new amide local anaesthetic agent. Acta Anaesthesiol Scand 1989; 33: 93-98
11. Scott D B, Lee A, Fagan D, Bowler G M R, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69: 563-569
12. Alahuhta S, Räsänen J, Jouppila P, et al. The effects of epidural ropivacaine and bupivacaine for cesarean section on uteroplacental and fetal circulation. Anesthesiology 1995; 83: 23-32
13. Zakowski M I, Ham A A, Grant G J. Transfer and uptake of alfentanil in the human placenta during in vitro perfusion. Anesth Analg 1994; 79: 1089-1093
14. Ala-Kokko T I, Pienimäki P, Herva R, Hollmén A I, Pelkonen O, Vähäkangas K. Transfer of lidocaine and bupivacaine across the isolated perfused human placenta. Pharmacol Toxicol 1995; 77: 142-148
15. Johnson R F, Herman N, Arney T L, Gonzalez H, Johnson H V, Downing J W. Bupivacaine transfer across the human term placenta. A study using the dual perfused human placental model. Anesthesiology 1995; 82: 459-468
16. Björk M, Pettersson K-J, Österlöf G. Capillary gas chromatographic method for simultaneous determination of local anaesthetics in plasma samples. J Chromatogr 1990; 553: 229-234
17. Arvidsson T, Eklund E. Determination of free concentration of ropivacaine and bupivacaine in blood plasma by ultrafiltration and coupled-column liquid chromatography. J Chromatogr B Biomed Appl 1995; 668: 91-98
18. Datta S, Camann W, Bader A, VanderBurgh L. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section. Anesthesiology 1995; 82: 1346-1352
19. Griffin R P, Reynolds F. Extradural anaesthesia for caesarean section: a double-blind comparison of 0.5% ropivacaine with 0.5% bupivacaine. Br J Anaesth 1995; 74: 512-516
20. Petersen M C, Moore R G, Nation R L, McMeniman W. Relationship between the transplacental gradients of bupivacaine and alpha 1 acid glycoprotein. Br J Clin Pharmacol 1981; 12: 859-862
21. Nau H. Clinical pharmacokinetics in pregnancy and perinatology. I. Placental transfer and fetal side effects of local anaesthetic agents. Dev Pharmacol Ther 1985; 8: 149-181
22. Thomas J, Long G, Moore G, Morgan D. Plasma protein binding and placental transfer of bupivacaine. Clin Pharmacol Ther 1976; 19: 426-434
23. Morrison L M M, Emanuelsson B M, McClure J H, et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine. Br J Anaesth 1994; 72: 164-169
24. Rutten A J, Mather L E, Nancarrow C, Sloan P A, McLean C F. Cardiovascular effects and regional clearances of intravenous ropivacaine in sheep. Anesth Analg 1990; 70: 577-582
25. Tucker G T, Wiklund L, Berlin-Wahlen A, Mather L E. Hepatic clearance of local anesthetics in man. J Pharmacokinet Biopharm 1977; 5: 111-122
26. Tucker G T. Pharmacokinetics of local anaesthetics. Br J Anaesth 1986; 58: 717-731
27. Kuhnert B R, Kuhnert P M, Gross T L. The disposition of bupivacaine following epidural anesthesia for cesarean section. Anesthesiology 1982; 57: 249-250
28. Kuhnert B R, Zuspan K J, Kuhnert P M, Syracuse C D, Brown D E. Bupivacaine disposition in mother, fetus and neonate after spinal anesthesia for cesarean section. Anesth Analg 1987; 66: 407-412
29. Carson R J, Reynolds F. Maternal-fetal distribution of bupivacaine in the rabbit. Br J Anaesth 1988; 61: 332-337
30. Reynolds F, Laishley R, Morgan B, Lee A. Effect of time and adrenaline in the feto-maternal distribution of bupivacaine. Br J Anaesth 1989; 62: 509-514
31. Wood M. Plasma binding and limitation of drug access to site of action. Anesthesiology 1991; 75: 721-723
32. Pacifici G M, Viani A. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences. Clin Pharmacokinet 1992; 23: 449-468
33. Fletcher S, Carson R, Reynolds F, Howell P, Morgan B. Plasma total and free concentrations of bupivacaine and lignocaine in mother and fetus following epidural administration, singly or together. International Journal of Obstetric Anesthesia 1992; 1: 135-140